Serum Adiponectin and Progression of Diabetic Nephropathy in Patients With Type 1 Diabetes
Markku Saraheimo(Helsinki University Hospital), Milla Rosengård‐Bärlund, Carol Forsblom(University of Helsinki), Per‐Henrik Groop(University of Helsinki), Jan Frystyk(Odense University Hospital), Allan Flyvbjerg(Aarhus University Hospital), Daniel Gordin(Helsinki University Hospital), Lena M. Thorn(University of Helsinki), Outi Heikkilä(Helsinki University Hospital), Johan Wadén(Helsinki University Hospital), Kustaa Hietala(Helsinki University Hospital)
Cited by 88
Related Papers
The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
|Diabetes|2009|641
Metabolomics Reveals Signature of Mitochondrial Dysfunction in Diabetic Kidney Disease
|Journal of the American Society of Nephrology|2013|578
Effect of Liraglutide, a Glucagon-Like Peptide-1 Analogue, on Left Ventricular Function in Stable Chronic Heart Failure Patients with and Without Diabetes (LIVE)—a Multicentre, Double-Blind, Randomised, Placebo-Controlled Trial
|European Journal of Heart Failure|2016|561
Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
|Diabetes|1999|509
Metabolic Syndrome in Type 1 Diabetes
|Diabetes Care|2005|428